Colm Fagan
Registered User
- Messages
- 755
In response to popular demand, e.g.,
The ARF's overall return in 2023 was 18.5%, in contrast with the negative 8.0% in 2022. In the 13 years since I started it (and a related AMRF) in December 2010 the performance has been heartening. For every €100,000 invested at the start, I withdrew €102,091 (an average of around 6% a year on prevailing value) and earned a return of €188,046. The net result is that the value at 31 December 2023 for every €100,000 invested in December 2010 was €185,955. The lowest yearly return in the period was minus 15.3% (in 2018) and the highest was 45.3% (in 2019).
The good long-term return can be attributed to three factors: (i) investing entirely in equities, (ii) keeping cash to a minimum and (iii) keeping costs low. That's exactly my prescription for the smoothed equity approach to AE.
My stock selection wasn't great, to put it mildly. I would have done far better by investing in a passive world equity fund.
In the entire 13 years, I recall making just one bond investment, and that was for a special reason, which I'll recount at some stage. Otherwise, I steered clear of this asset class for the simple reason that the expected return on bonds (in the mathematical sense) is around 4% a year less than from equities. The same is true for cash. I wouldn't fancy paying an extra management charge of 4% a year on a portion of my portfolio, which is what I would effectively be doing, by my reckoning, if I invested in bonds or cash on deposit. No, thanks.
There were no purchases or sales during the year: the holdings at year end were exactly the same as at the start. Zero trading helped keep costs down. I had to take an income of 6% in the year. That came entirely from dividends on existing holdings and by running down the cash portion of the fund from 2.6% at the start to 0.6% at the end.
The passive investment approach wasn't by choice. I just didn't have time to research possible purchases (or sales) because of my preoccupation with trying to convince government to commission an independent evaluation of my proposal for a smoothed equity approach to AE, a campaign that everyone on AAM must be aware of by now. Also, as I get older, I will inevitably make fewer purchases and sales. I envisage very few purchases for the rest of my days. It will be nearly all sales as I run down the portfolio.
The best performer in 2023 by far was Novo Nordisk, which I wrote about in 2019 (see here). As an aside, its spectacular performance since I bought it has nothing to do with my stated reasons for buying it in the first place! In other words, I was just lucky.
I bought my entire current holding in the company in 2020. At end September 2020, just after the purchases, Novo Nordisk accounted for 7.4% of my ARF portfolio. Even by my standards, that was a large investment in a single asset. By 31 December 2023, its share of my ARF portfolio had increased to over 20%, purely as a result of capital appreciation. The price had increased from the average DKr205 when I bought in 2020 (DKr410 before a 2 for 1 share split), to DKr698 at 31 December 2023, at which time it represented over 20% of my ARF. I also got dividends in the period. Novo Nordisk alone contributed not far short of 8% of the total return of 18.5% in 2023.
The second best performer in 2023 was Apple, accounting for almost 7% of the 18.5% return.
The worst performer in 2023 was my single biggest ARF investment: Phoenix Group Holdings. It contributed almost a negative 1% to the total return.
The second worst contributor to the total return was fees! It has proven very difficult to persuade ARF providers to cut their fees, despite the fact that all I'm asking of them is a bit of bookkeeping. I've finally taken steps to reduce the fees charged to my account.
With the benefit of hindsight, I invested far too much in the UK (probably because I think I'm familiar with that market from reading the FT). I would have done far better if I had steered clear of the UK entirely.
In total, my ARF only has holdings in 11 shares. If I had many more, I simply wouldn't be able to keep track of them.
here, for @Bluefin and others, is an update on the performance of my ARF.Good to see you back Colm... I appreciate your insights on investing.
As we approach the end of the trading year how did your investments survive volatile period we all have experienced
The ARF's overall return in 2023 was 18.5%, in contrast with the negative 8.0% in 2022. In the 13 years since I started it (and a related AMRF) in December 2010 the performance has been heartening. For every €100,000 invested at the start, I withdrew €102,091 (an average of around 6% a year on prevailing value) and earned a return of €188,046. The net result is that the value at 31 December 2023 for every €100,000 invested in December 2010 was €185,955. The lowest yearly return in the period was minus 15.3% (in 2018) and the highest was 45.3% (in 2019).
The good long-term return can be attributed to three factors: (i) investing entirely in equities, (ii) keeping cash to a minimum and (iii) keeping costs low. That's exactly my prescription for the smoothed equity approach to AE.
My stock selection wasn't great, to put it mildly. I would have done far better by investing in a passive world equity fund.
In the entire 13 years, I recall making just one bond investment, and that was for a special reason, which I'll recount at some stage. Otherwise, I steered clear of this asset class for the simple reason that the expected return on bonds (in the mathematical sense) is around 4% a year less than from equities. The same is true for cash. I wouldn't fancy paying an extra management charge of 4% a year on a portion of my portfolio, which is what I would effectively be doing, by my reckoning, if I invested in bonds or cash on deposit. No, thanks.
There were no purchases or sales during the year: the holdings at year end were exactly the same as at the start. Zero trading helped keep costs down. I had to take an income of 6% in the year. That came entirely from dividends on existing holdings and by running down the cash portion of the fund from 2.6% at the start to 0.6% at the end.
The passive investment approach wasn't by choice. I just didn't have time to research possible purchases (or sales) because of my preoccupation with trying to convince government to commission an independent evaluation of my proposal for a smoothed equity approach to AE, a campaign that everyone on AAM must be aware of by now. Also, as I get older, I will inevitably make fewer purchases and sales. I envisage very few purchases for the rest of my days. It will be nearly all sales as I run down the portfolio.
The best performer in 2023 by far was Novo Nordisk, which I wrote about in 2019 (see here). As an aside, its spectacular performance since I bought it has nothing to do with my stated reasons for buying it in the first place! In other words, I was just lucky.
I bought my entire current holding in the company in 2020. At end September 2020, just after the purchases, Novo Nordisk accounted for 7.4% of my ARF portfolio. Even by my standards, that was a large investment in a single asset. By 31 December 2023, its share of my ARF portfolio had increased to over 20%, purely as a result of capital appreciation. The price had increased from the average DKr205 when I bought in 2020 (DKr410 before a 2 for 1 share split), to DKr698 at 31 December 2023, at which time it represented over 20% of my ARF. I also got dividends in the period. Novo Nordisk alone contributed not far short of 8% of the total return of 18.5% in 2023.
The second best performer in 2023 was Apple, accounting for almost 7% of the 18.5% return.
The worst performer in 2023 was my single biggest ARF investment: Phoenix Group Holdings. It contributed almost a negative 1% to the total return.
The second worst contributor to the total return was fees! It has proven very difficult to persuade ARF providers to cut their fees, despite the fact that all I'm asking of them is a bit of bookkeeping. I've finally taken steps to reduce the fees charged to my account.
With the benefit of hindsight, I invested far too much in the UK (probably because I think I'm familiar with that market from reading the FT). I would have done far better if I had steered clear of the UK entirely.
In total, my ARF only has holdings in 11 shares. If I had many more, I simply wouldn't be able to keep track of them.
Last edited: